Evidence map›Paper›PMID 24717189›Full record

ArticleGlobal health action2014

High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.

Lucas Molfino, Ajay M V Kumar, Petros Isaakidis, Rafael Van den Bergh, Mohamed Khogali, Sven G Hinderaker, Alice Magaia, Sheila Lobo, Celeste Gracia Edwards, Jan Walter

Abstract read
In one paragraph

Article in Global health action, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lucas MolfinoMédecins Sans Frontières, Maputo, Mozambique; lucasmolfino@yahoo.com.ar.
Ajay M V KumarInternational Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office, New Delhi, India.
Petros IsaakidisMédecins Sans Frontières (MSF), Operational Research Unit, Luxembourg City, Luxembourg.
Rafael Van den BerghMédecins Sans Frontières (MSF), Operational Research Unit, Luxembourg City, Luxembourg.
Mohamed KhogaliMédecins Sans Frontières (MSF), Operational Research Unit, Luxembourg City, Luxembourg.
Sven G HinderakerCentre for International Health, University of Bergen, Bergen, Norway.
Alice MagaiaDirecçao de Saude da Cidade de Maputo (DSCM), Ministry of Health, Maputo, Mozambique.
Sheila LoboDirecçao de Saude da Cidade de Maputo (DSCM), Ministry of Health, Maputo, Mozambique.
Celeste Gracia EdwardsMédecins Sans Frontières, Maputo, Mozambique.
Jan WalterMédecins Sans Frontières, Maputo, Mozambique.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Mozambique, antiretroviral therapy (ART) scale-up has been successfully implemented. However, attrition in care remains a major programmatic challenge. In 2009, an intermediary-level HIV referral center was created in Maputo to ensure access to specialized care for HIV-infected patients with complications (advanced clinical-immunological stage, Kaposi sarcoma, or suspected ART failure).

objectiveTo determine the attrition from care and to identify risk factors that lead to high attrition among patients referred to an intermediary-level HIV referral center.

designThis was a retrospective cohort study from 2009 to 2011.

resultsA total of 1,657 patients were enrolled, 847 (51%) were men, the mean age was 36 years (standard deviation: 11), the mean CD4 count was 27 cells/µl (interquartile range: 11-44), and one-third were severely malnourished. The main reasons for referral were advanced clinical stages (WHO stages 3 and 4, and CD4 count <50 cells/µl) in 70% of the cases, and 19% had Kaposi sarcoma. The overall attrition rate was 28.7 per 100 person-years (PYs) - the mortality rate was 5.0 (95% confidence interval [CI]: 4.2-5.9) per 100 PYs, and the loss-to-follow-up rate was 23.7 (95% CI: 21.9-25.6) per 100 PYs. There were 793 attritions - 137 deaths and 656 lost to follow-up (LTFU); 77% of all attrition happened within the first year. The factors independently associated with attrition were male sex (adjusted hazard ratio [aHR]: 1.15, 95% CI: 1.0-1.3), low body mass index (aHR: 1.51, 95% CI: 1.2-1.8), WHO clinical stage 3 or 4 (aHR: 1.30, 95% CI: 1.0-1.6; and aHR: 1.91, 95% CI: 1.4-2.5), later year of enrollment (aHR 1.61, 95% CI 1.3-1.9), and 'being already on ART' at enrollment (aHR 13.71, 95% CI 11.4-16.4).

conclusionsAttrition rates among HIV-infected patients enrolled in an intermediary referral center were high, mainly related to advanced stage of clinical disease. Measures are required to address this, including innovative strategies for HIV-testing uptake, earlier ART initiation and nutritional supplementation, and special attention to men and those who are already on ART at enrolment. Qualitative research is required to understand the reasons for being LTFU and design informed evidence-based interventions.

Indexed as

Drug MonitoringAdultAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansMaleMedication AdherenceMiddle AgedMozambiqueRetrospective StudiesRisk FactorsSecondary Care CentersYoung AdultAnti-HIV AgentsattritionHIV referral centeroperational researchresource-limited settingsretention in care

Identifiers

PMID24717189
PMCPMC3982117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.